Patients with SLE and pSS have elevated serum levels of BAFF [5, 6], and serum levels of BAFF correlate with autoantibody levels [6–8] and have been found to be associated with pSS-associated lymphoproliferative complications [9, 10]. The gene discussed is TNFSF13B; the disease is complication.